CD28 and Hepatic fibrosis: In adjusted analyses of the two primary outcomes, the proportion of CD8 + CD28-CD57+ T-cells was lower among those with advanced liver fibrosis/cirrhosis, but the difference was not statistically significant (adjusted mean difference [95% confidence interval, CI]: − 0.36 [− 7.35, 6.63].